Anterix (ATEX) Stock Forecast, Price & News

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Anterix in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ATEX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ATEX, but not buy additional shares or sell existing shares.
View ATEX analyst ratings or view top-rated stocks.

1 Wall Street analysts have issued 1 year price objectives for Anterix's stock. Their ATEX share price forecasts range from $41.00 to $41.00. On average, they predict the company's share price to reach $41.00 in the next twelve months. This suggests a possible upside of 30.5% from the stock's current price.
View analysts price targets for ATEX or view top-rated stocks among Wall Street analysts.

Anterix's stock was trading at $32.17 at the beginning of the year. Since then, ATEX stock has decreased by 2.3% and is now trading at $31.42.
View the best growth stocks for 2023 here.

Anterix saw a increase in short interest in September. As of September 15th, there was short interest totaling 1,240,000 shares, an increase of 6.9% from the August 31st total of 1,160,000 shares. Based on an average daily volume of 217,600 shares, the short-interest ratio is currently 5.7 days.
View Anterix's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, October 30th 2023.
View our ATEX earnings forecast.

Anterix Inc. (NASDAQ:ATEX) issued its quarterly earnings data on Wednesday, August, 2nd. The company reported ($0.11) earnings per share for the quarter, topping analysts' consensus estimates of ($0.59) by $0.48. The firm earned $0.61 million during the quarter, compared to analysts' expectations of $1.18 million. Anterix had a negative net margin of 239.01% and a negative trailing twelve-month return on equity of 19.10%.

SPDR S&P Telecom ETF holds 14,612 shares of ATEX stock, representing 0.74% of its portfolio.

Based on aggregate information from My MarketBeat watchlists, some companies that other Anterix investors own include Pfizer (PFE), AbbVie (ABBV), Advanced Micro Devices (AMD), Cisco Systems (CSCO), International Business Machines (IBM), Micron Technology (MU), Occidental Petroleum (OXY), Stericycle (SRCL) and Applied Optoelectronics (AAOI).

Anterix trades on the NASDAQ under the ticker symbol "ATEX."

Anterix's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Heard Capital LLC (9.26%), BlackRock Inc. (7.05%), State Street Corp (2.13%), Geode Capital Management LLC (2.06%), Dimensional Fund Advisors LP (1.97%) and Clearbridge Investments LLC (1.66%). Insiders that own company stock include Christopher Guttman-Mccabe, Elaine Gangeri, Gena L Ashe, Hamid Akhavan, Leslie B Daniels, Leslie B Daniels, Mahvash Yazdi, Morgan E Obrien, Owl Creek Asset Management, L, Robert Harris Schwartz, Ryan Gerbrandt and Timothy Gray.
View institutional ownership trends.

Shares of ATEX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ATEX stock can currently be purchased for approximately $31.42.

Anterix (NASDAQ:ATEX) has a market capitalization of $598.55 million and generates $1.92 million in revenue each year. The company earns $-16,320,000.00 in net income (profit) each year or ($0.27) on an earnings per share basis.

Anterix's mailing address is 3 GARRET MOUNTAIN PLAZA SUITE 401, WOODLAND PARK NJ, 07424. The official website for the company is www.anterix.com. The company can be reached via phone at (973) 771-0300, via email at nvecchiarelli@anterix.com, or via fax at 888-858-6245.